Literature DB >> 15036827

Low heart rate variability is a risk factor for sudden cardiac death in type 2 diabetes.

Masaaki Kataoka1, Chikako Ito, Hideo Sasaki, Kiminori Yamane, Nobuoki Kohno.   

Abstract

The purpose of this study is to examine the association between sudden cardiac death (SCD) and heart rate variability (HRV) in subjects with and without type 2 diabetes and to determine whether low HRV can predict SCD in type 2 diabetes. Subjects were 8917 consecutively examined persons (3089 diabetic, and 5828 nondiabetic subjects) aged 35-69 years who underwent a 75 g oral glucose tolerance test (OGTT) together with electrocardiography (ECG). HRV was calculated from the 12-lead ECG as the coefficient of variance for 100 R-R intervals (CV(R-R)). During a median observation period of 5.2 years, SCD occurred in 56 subjects (33 diabetic, and 23 nondiabetic). Among diabetic subjects, mortality from SCD tended to be higher in subjects with a low CV(R-R) (P=0.004). After adjustment for age, gender, systolic blood pressure, total cholesterol (TC), triglycerides (TG), BMI, ischemic ECG change, and smoking history, relative risk (RR) of SCD was 2.07 (95% CI 1.02-4.17) in diabetic subjects with a CV(R-R) <2.2% compared with those with a CV(R-R) > or =2.2%. Diabetic subjects with a CV(R-R) <2.2% had significantly higher cumulative mortality from SCD than those with a CV(R-R) > or =2.2% (P=0.007). In type 2 diabetes, a low CV(R-R) carried an increased risk of SCD.

Entities:  

Mesh:

Year:  2004        PMID: 15036827     DOI: 10.1016/j.diabres.2003.10.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  31 in total

Review 1.  Improvements in heart rate variability with exercise therapy.

Authors:  Faye S Routledge; Tavis S Campbell; Judith A McFetridge-Durdle; Simon L Bacon
Journal:  Can J Cardiol       Date:  2010 Jun-Jul       Impact factor: 5.223

2.  Trans-fatty acid consumption and heart rate variability in 2 separate cohorts of older and younger adults.

Authors:  Luisa Soares-Miranda; Phyllis K Stein; Fumiaki Imamura; Jacob Sattelmair; Rozenn N Lemaitre; David S Siscovick; Jorge Mota; Dariush Mozaffarian
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-07-06

3.  Effects of impaired glucose metabolism on heart rate variability and blood pressure variability in essential hypertension patients.

Authors:  Gang Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Victoria Delgado; Jurriaan A Kok; Mieke T J Bus; Arie C Maan; Marcel P Stokkel; Antje V Kharagitsingh; Petra Dibbets-Schneider; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-22       Impact factor: 9.236

Review 5.  Diabetes and cardiovascular autonomic dysfunction: application of animal models.

Authors:  Katia De Angelis; Maria Claudia Irigoyen; Mariana Morris
Journal:  Auton Neurosci       Date:  2008-12-02       Impact factor: 3.145

6.  Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes.

Authors:  Xu Dong; Panagiota T Foteinou; Steven E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

7.  A Pocket-size Device to Detect Autonomic Neuropathy.

Authors:  Niels Ejskjaer; Jesper Fleischer; Jacob Fleischer; Poul Erik Jacobsen; Per Logstrup Poulsen; Hans Nygaard
Journal:  J Diabetes Sci Technol       Date:  2008-07

8.  Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial.

Authors:  Badar U Jan; Susette M Coyle; Leo O Oikawa; Shou-En Lu; Steve E Calvano; Paul M Lehrer; Stephen F Lowry
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

9.  Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP.

Authors:  Ho-Jin Park; Serban P Georgescu; Chuang Du; Christopher Madias; Mark J Aronovitz; C Michael Welzig; Bo Wang; Ulrike Begley; Yali Zhang; Robert O Blaustein; Richard D Patten; Richard H Karas; Herbert H Van Tol; Timothy F Osborne; Hitoshi Shimano; Ronglih Liao; Mark S Link; Jonas B Galper
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

10.  Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.

Authors:  Deanna L Kelly; Robert P McMahon; Fang Liu; Raymond C Love; Heidi J Wehring; Joo-Cheol Shim; Kimberly R Warren; Robert R Conley
Journal:  J Clin Psychiatry       Date:  2010-01-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.